Real-time enrollment status for this type 2 diabetes clinical trial
Current Status
Recruiting
Checked: October 5, 2026 at 10:03 PM UTC
| NCT Number | NCT07754461 |
| Recruiting Status | Recruiting |
| Condition | Type 2 Diabetes |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 89 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | September 30, 2026 (5 days ago) |
As of October 5, 2026: Clinical trial NCT07754461 is currently recruiting participants. This phase3 study for type 2 diabetes is actively seeking new participants at 89 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07754461 is actively recruiting participants as of October 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 89 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07754461 was last updated 5 days ago (September 30, 2026). HelloStudys verifies this status automatically.